"The Taub Institute for Research on Alzheimer's Disease and the Aging Brain is the nucleus of a dynamic, multidisciplinary endeavor. The Institute brings together Columbia University researchers and clinicians to uncover the causes of Alzheimer's, Parkinson's and other age-related brain diseases and to discover ways to prevent and cure these diseases"

During the past decade, Columbia University Taub Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University Taub Institute" #1 collaborator was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Columbia University Taub Institute" are "Alzheimer's Disease" (2 trials), "Alzheimer Disease" (1 trials) and "Behavioral Variant Frontotemporal Dementia" (1 trials). Many other conditions were trialed in "Columbia University Taub Institute" in a lesser frequency.

Most popular intervention types in "Columbia University Taub Institute" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACC-001 (10 mcg) + QS-21" (1 trials), "ACC-001+ QS21 (3mcg)" (1 trials), "ACC-001+QS-21 (30mcg)" (1 trials), "LMTM" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Taub Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University Taub Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Columbia University Taub Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Taub Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".